TG Therapeutics, Inc. (TGTX)

Nasdaq · Healthcare · Biotechnology
$63.34-2.37%As of 2026-11-22 · USD
Last session low $63.12Last session high $65.64
52-week low $26.7652-week high $68.03
Market cap
$9.57B
Sector
Healthcare
P/E (TTM)
94.5x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)59.2In the neutral range (30 to 70)
MACD (12, 26, 9)2.32Above its signal line (2.21); histogram 0.11
Bollinger %B (20, 2)64%Inside the bands (55.11 to 67.99)
SMA 2061.55Price is 2.9% above
SMA 5057.59Price is 10.0% above
SMA 20046.25Price is 37.0% above
ATR (20)4.55% of priceAverage true range per day
52-week position89%In the upper part of the 26.76 to 68.03 range

About TG Therapeutics, Inc.

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Insider filings, 90 daysNo purchases and 1 sale (about $275K).
Latest fiscal yearEnded 2025-12-31: revenue of $616.29M and an operating margin of 20.0%.

More in Biotechnology